Search Results - Heather A Wakelee
- Showing 1 - 14 results of 14
-
1
-
2
Bevacizumab’s Association With a Decreased Risk of Brain Metastases in ECOG-ACRIN E1505, a Phase 3 Randomized Trial of Adjuvant Chemotherapy With or Without Bevacizumab in Surgical... by John M. Varlotto, MD, Yating Wang, MS, Zhuoxin Sun, PhD, Heather A. Wakelee, MD, Suresh Ramalingam, MD, Joan Schiller, MD
Published in JTO Clinical and Research Reports (2022-03-01)Get full text
Article -
3
Central Nervous System Progression in Patients Receiving ALK-Targeted Central Nervous System–Penetrable Tyrosine Kinase Inhibitors: Treatment Patterns and Outcomes by Surbhi Singhal, MD, Caressa Hui, MD, Joel W. Neal, MD, PhD, Seema Nagpal, MD, Mohana Roy, MD, Millie Das, MD, Kavitha Ramchandran, MD, Erqi Pollom, MD, Giovanni Selvaggi, MD, Heather A. Wakelee, MD, Nathaniel J. Myall, MD
Published in JTO Clinical and Research Reports (2025-12-01)Get full text
Article -
4
Real-world risk of brain metastases in stage III non-small cell lung cancer in the era of PET and MRI staging by Saud Alhusaini, Tyler A. Lanman, Ryan B. Ko, Kate E. Therkelsen, Rie Von Eyben, Maximilian Diehn, Scott G. Soltys, Erqi L. Pollom, Alexander Chin, Lucas Vitzthum, Heather A. Wakelee, Sukhmani K. Padda, Kavitha Ramchandran, Billy W. Loo, Joel W. Neal, Seema Nagpal
Published in Frontiers in Oncology (2023-03-01)Get full text
Article -
5
Population‐based differences in the outcome and presentation of lung cancer patients based upon racial, histologic, and economic factors in all lung patients and those with metasta... by John Michael Varlotto, Richard Voland, Kerrie McKie, John C. Flickinger, Malcolm M. DeCamp, Debra Maddox, Paul Rava, Thomas J. Fitzgerald, Geoffrey Graeber, Negar Rassaei, Paulo Oliveira, Suhail Ali, Chandra Belani, Jonathan Glanzman, Heather A. Wakelee, Manali Patel, Jennifer Baima, Jianying Zhang, William Walsh
Published in Cancer Medicine (2018-04-01)Get full text
Article -
6
Brief Report: Prospective Trial of Pembrolizumab Monotherapy in Metastatic NSCLC Evaluating Circulating Tumor DNA as a Surrogate Biomarker of Response by Iris van 't Erve, PhD, Isabelle Blanchard, BS, Judy Y. Pagtama, MSN, Alison J. Holmes Tisch, MSN, Ash A. Alizadeh, MD, PhD, Kavitha Ramchandran, MD, Heather A. Wakelee, MD, Sukhmani K. Padda, MD, Maximilian Diehn, MD, PhD, Joel W. Neal, MD, PhD
Published in JTO Clinical and Research Reports (2025-09-01)Get full text
Article -
7
Afatinib and Necitumumab in EGFR-Mutant NSCLC with Acquired Resistance to Tyrosine Kinase Inhibitors by Nathaniel J. Myall, MD, Jennifer G. Whisenant, PhD, Joel W. Neal, MD, PhD, Wade T. Iams, MD, Karen L. Reckamp, MD, Sally York, MD, PhD, Lynne D. Berry, PhD, Yu Shyr, PhD, Leora Horn, MD, Heather A. Wakelee, MD, Sukhmani K. Padda, MD
Published in JTO Clinical and Research Reports (2025-02-01)Get full text
Article -
8
DLL3 Immunohistochemical Expression in Neuroendocrine-Transformed EGFR-Mutant Lung Cancer and Two Cases of Tarlatamab Therapy by Jacqueline V. Aredo, MD, MS, Surbhi Singhal, MD, Gerald J. Berry, MD, Farshad Moradi, MD, PhD, Heather A. Wakelee, MD, Nathaniel J. Myall, MD, Kavitha J. Ramchandran, MD, Millie Das, MD, Carlos J. Suarez, MD, MS, Joel W. Neal, MD, PhD, Jonathan W. Riess, MD, MS
Published in JTO Clinical and Research Reports (2025-12-01)Get full text
Article -
9
Etirinotecan Pegol (NKTR‐102) in Patients With Active Brain Metastases From Lung or Breast Cancer by Seema Nagpal, Kim‐Son Nguyen, Sophie Bertrand, Kristen May Cunanan, Sukhmani K. Padda, Judy Y. Pagtama, Alison Holmes Tisch, Gwen Coffey, Reena P. Thomas, George W. Sledge Jr, Joshua Gruber, Melinda L. Telli, Mark Pegram, Lawrence D. Recht, Heather A. Wakelee, Scott G. Soltys, Suleiman A. Massarweh, Joel W. Neal
Published in Cancer Reports (2025-09-01)Get full text
Article -
10
High-Dose Osimertinib for CNS Progression in EGFR+ NSCLC: A Multi-Institutional Experience by A.J. Piper-Vallillo, MD, Julia K. Rotow, MD, Jacqueline V. Aredo, MD, Khvaramze Shaverdashvili, MD, PhD, Jia Luo, MD, Jennifer W. Carlisle, MD, Hatim Husain, MD, Alona Muzikansky, MA, Rebecca S. Heist, MD, Deepa Rangachari, MD, Suresh S. Ramalingam, MD, Heather A. Wakelee, MD, Helena A. Yu, MD, Lecia V. Sequist, MD, Joshua M. Bauml, MD, Joel W. Neal, MD, PhD, Zofia Piotrowska, MD, MHS
Published in JTO Clinical and Research Reports (2022-06-01)Get full text
Article -
11
Osimertinib in NSCLC With Atypical EGFR-Activating Mutations: A Retrospective Multicenter Study by Jingran Ji, MD, Jacqueline V. Aredo, MD, MS, Andrew Piper-Vallillo, MD, Laura Huppert, MD, Julia K. Rotow, MD, Hatim Husain, MD, Susan Stewart, PhD, Rosemary Cobb, BS, Heather A. Wakelee, MD, Collin M. Blakely, MD, PhD, Melisa L. Wong, MD, MAS, Matthew A. Gubens, MD, MS, Mohammad H. Madani, MD, Subba R. Digumarthy, MD, Caroline McCoach, MD, PhD, Zofia Piotrowska, MD, MHS, Joel W. Neal, MD, PhD, Jonathan W. Riess, MD, MS
Published in JTO Clinical and Research Reports (2023-03-01)Get full text
Article -
12
Phase II Trial of Regorafenib and Oral Methotrexate in Previously Treated Advanced KRAS-Mutant NSCLC by Jacqueline V. Aredo, MD, MS, Heather A. Wakelee, MD, Kavitha J. Ramchandran, MD, Joel W. Neal, MD, PhD, Maximilian Diehn, MD, PhD, Angela Bik-Yu Hui, PhD, Ameen Salahudeen, MD, PhD, Bernice Kwong, MD, Gerald J. Berry, MD, H. Henry Guo, MD, PhD, Kristen Cunanan, PhD, Shireen Vali, PhD, Danny Pancirer, BA, Vivian Tsang, MSN, Grace Hwang, MS, Monica Loza, BA, Brittany Johnson, BA, Isabelle Blanchard, BS, Sukhmani K. Padda, MD
Published in JTO Clinical and Research Reports (2024-12-01)Get full text
Article -
13
Predicting benefit from immune checkpoint inhibitors in patients with non-small-cell lung cancer by CT-based ensemble deep learning: a retrospective study by Maliazurina B Saad, PhD, Lingzhi Hong, MD, Muhammad Aminu, MD, Natalie I Vokes, MD, Pingjun Chen, PhD, Morteza Salehjahromi, PhD, Kang Qin, MD, Sheeba J Sujit, PhD, Xuetao Lu, PhD, Elliana Young, MS, Qasem Al-Tashi, PhD, Rizwan Qureshi, PhD, Carol C Wu, ProfMD, Brett W Carter, ProfMD, Steven H Lin, ProfMD, Percy P Lee, ProfMD, Saumil Gandhi, MD, Joe Y Chang, ProfMD, Ruijiang Li, PhD, Michael F Gensheimer, MD, Heather A Wakelee, ProfMD, Joel W Neal, MD, Hyun-Sung Lee, MD, Chao Cheng, PhD, Vamsidhar Velcheti, ProfMD, Yanyan Lou, MD, Milena Petranovic, MD, Waree Rinsurongkawong, PhD, Xiuning Le, MD, Vadeerat Rinsurongkawong, PhD, Amy Spelman, PhD, Yasir Y Elamin, MD, Marcelo V Negrao, MD, Ferdinandos Skoulidis, MD, Carl M Gay, MD, Tina Cascone, MD, Mara B Antonoff, MD, Boris Sepesi, MD, Jeff Lewis, BS, Ignacio I Wistuba, ProfMD, John D Hazle, ProfPhD, Caroline Chung, MD, David Jaffray, ProfPhD, Don L Gibbons, ProfMD, Ara Vaporciyan, ProfMD, J Jack Lee, ProfPhD, John V Heymach, ProfMD, Jianjun Zhang, MD, Jia Wu, PhD
Published in The Lancet: Digital Health (2023-07-01)Get full text
Article -
14
Transformer-based AI approach to unravel long-term, time-dependent prognostic complexity in patients with advanced NSCLC and PD-L1 ≥50%: insights from the pembrolizumab 5-year glob... by Danilo Rocco, Mieke Van Hemelrijck, Salvatore Grisanti, Avinash Aujayeb, Martin Forster, Giannis Mountzios, Bruno Vincenzi, Joachim G J V Aerts, Orla Fitzpatrick, Solange Peters, Alex Friedlaender, Alfredo Addeo, Giuseppe Lo Russo, Roberto Ferrara, Marina Chiara Garassino, Diego Signorelli, Alessandro Russo, So Yeon Kim, Vincenzo Sforza, Jarushka Naidoo, Scott Gettinger, Martin Sebastian, Balazs Halmos, Abdul Rafeh Naqash, Alessio Cortellini, Raffaele Giusti, Marcello Tiseo, Michele De Tursi, Federica Zoratto, Marco Russano, Rita Chiari, Biagio Ricciuti, Andrea De Giglio, Alain Gelibter, Heather A Wakelee, Paolo Soda, Giuseppe Tonini, Amin H Nassar, Alessandra Curioni-Fontecedro, Eleni Karapanagiotou, Emilio Bria, Paolo Bironzo, Joao V Alessi, David J Pinato, Giuseppe L Banna, Francesco Passiglia, Carlo Genova, Francesca Mazzoni, Alessandro Inno, Francesco Grossi, Luca Cantini, Lorenza Landi, Luigi Della Gravara, Frank Aboubakar Nana, Ernest Nadal, Uma Mukherjee, Federica Biello, Annalisa Guida, Marianna Macerelli, Gabriele Minuti, Giulio Metro, Eleni Josephides, Andrea Camerini, Elisa Roca, David O’Reilly, Mingjia Li, Dwight H Owen, Antonio D’Alessio, Laura Mezquita, Aida Piedra, Teresa Gorría, Claudia A M Fulgenzi, Joel W Neal, Javier Baena, Jacobo Rogado, Mary Jo Fidler, Arsela Prelaj, Teresa Beninato, Federica Pecci, Alessandro Di Federico, Kazuki Takada, Leonardo Brunetti, Talal El Zarif, Laura Moliner, Alberto Servetto, Sukumar Kalvapudi, Sai Yendamuri, Valentina Santo, Edoardo Garbo, Monica Loza, Ritujith Jayakrishnan, Michele Montrone, Bartlomiej Tomasik, Maximilian Rost, Isabelle Monnet, Francesco Agustoni, Sara Ramella, Artur Katz, Michele Ghidini, Armida D’Incecco, Gianpaolo Spinelli, Monica Verrico, Manuel Dupont, Rafael Di Marco Barros, Diego Luigi Cortinovis, Chiara Bennati, Anne-Marie Dingemans, Giulia La Cava, Kirsty Balachandran, Taher Abu Hejleh, Camillo Maria Caruso, Valerio Guarrasi
Published in Journal for ImmunoTherapy of Cancer (2025-09-01)Get full text
Article
